Trial Profile
A longitudinal cohort study to evaluate the teriparatide, denosmab, and bisphosphonates for prevention of vertebral fractures in patients with glucocorticoid-induced osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Teriparatide (Primary) ; Bisphosphonates
- Indications Corticosteroid-induced osteoporosis; Vertebral fracture
- Focus Therapeutic Use
- 01 Feb 2016 New trial record